Making sense of scoring systems in community acquired pneumonia

Respirology

Volumn 14, Issue 3, 2009, Pages 327-335

  Niederman, Michael S ^a,b  

^a WINTHROP UNIVERSITY HOSPITAL   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

Community acquired pneumonia; Mortality; Pneumonia Severity Index; Prognosis; Scoring system; Site of care decision

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; HYDROCORTISONE; PROCALCITONIN;

ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMMUNITY ACQUIRED PNEUMONIA; COMORBIDITY; CURB 65; ELDERLY CARE; HEALTH CARE ORGANIZATION; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; INTERMETHOD COMPARISON; MEDICAL DECISION MAKING; MEDICAL SOCIETY; MORTALITY; OUTCOME ASSESSMENT; PNEUMONIA SEVERITY INDEX; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SOCIAL ASPECT; TREATMENT PLANNING;

AGE FACTORS; AGED; AGED, 80 AND OVER; CALCITONIN; COMMUNITY-ACQUIRED INFECTIONS; HUMANS; PNEUMONIA; PROGNOSIS; PROTEIN PRECURSORS; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 63849299150     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2009.01494.x     Document Type: Article

References (51)

1. Niederman MS, McCombs JS, Unger AN, Kumar A, Popovian R. The cost of treating community-acquired pneumonia. Clin. Ther. 1998 20 : 820 37.
2. Fine MJ, Pratt HM, Obrosky DS, Lave JR, McIntosh LJ et al. Relation between length of stay and costs of care for patients with community-acquired pneumonia. Am. J. Med. 2000 109 : 378 85.
3. McCormick D, Fine MJ, Coley CM, Marrie TJ, Lave JR et al. Variation in length of hospital stay and its relation to medical outcomes in patients with community-acquired pneumonia. Am. J. Med. 1999 105 : 5 12.
4. Halm EA, Fine MJ, Marrie TJ, Coley CM, Kapoor WN et al. Time to clinical stability in patients hospitalized with community-acquired pneumonia. JAMA 1998 279 : 1452 7.
5. Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N. Engl J. Med. 1997 336 : 243 50.
6. Lim WS, van der Eerden MM, Laing R, Boersma WG, Karalus N et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 2003 58 : 377 82.
7. Niederman MS, Feldman C, Richards GA. Combining information from prognostic scoring tools for CAP: an American view on how to get the best of both worlds. Eur. Resp. J. 2006 27 : 9 11.
8. España PP, Capelastegui A, Gorordo I, Esteban C, Oribe M et al. Development and validation of a clinical prediction rule for severe community-acquired pneumonia. Am. J. Respir. Crit. Care Med. 2006 174 : 1249 56.
9. Charles PC, Wolfe R, Whitby M, Fine MJ, Fuller AJ et al. SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia. Clin. Infect. Dis. 2008 47 : 375 84.
10. Atlas SJ, Benzer TI, Borowsky LH, Chang Y, Burnham DC et al. Safely increasing the proportion of patients with community-acquired pneumonia treated as outpatients: an interventional trial. Arch. Intern. Med. 1998 158 : 1350 6.
11. Marrie TJ, Lau CY, Wheeler SL, Wong CJ, Vandervoort MK et al. A controlled trial of a critical pathway for treatment of community-acquired pneumonia. CAPITAL Study Investigators. Community-acquired pneumonia intervention trial assessing levofloxacin. JAMA 2000 283 : 749 55.
12. Renaud B, Coma E, Labarere J, Hayon J, Roy PM et al. Routine use of pneumonia severity index for guiding the site-of-treatment decision of patients with pneumonia in the emergency department: a multicenter, prospective, observational, controlled cohort study. Clin. Infect. Dis. 2007 44 : 41 9.
13. Carratala J, Fernandez-Sabe N, Ortega L, Castellsague X, Roson B et al. Outpatient care compared with hospitalization for community-acquired pneumonia: a randomized trial in low-risk patients. Ann. Intern. Med. 2005 142 : 165 72.
14. Marrie TJ, Huang JQ. Low-risk patients admitted with community-acquired pneumonia. Am. J. Med. 2005 118 : 1357 63.
15. Farr BM, Sloman AJ, Fisch MJ. Predicting death in patients hospitalized for community-acquired pneumonia. Ann. Intern. Med. 1991 115 : 428 36.
16. Capelastegui A, Espana PP, Quintana JM, Areitio I, Gorordo I et al. Validation of a predictive rule for the management of community-acquired pneumonia. Eur. Resp. J. 2006 27 : 151 7.
17. Bauer TT, Ewig S, Marre R, Suttorp N, Welte T the CAPNETZ group. CRB-65 predicts death from community-acquired pneumonia. J. Intern. Med. 2006 260 : 93 101.
18. Chalmers JD, Singanayagam A, Hill AT. Systolic blood pressure is superior to other haemodynamic predictors of outcome in community acquired pneumonia. Thorax 2008 63 : 698 702.
19. Aujesky D, Auble TE, Yealy DM, Stone RA, Obrosky DS et al. Prospective comparison of three validated prediction rules for prognosis in community-acquired pneumonia. Am. J. Med. 2005 118 : 384 92.
20. Angus DC, Marrie TJ, Obrosky DS, Clermont G, Dremslzov TT et al. Severe community-acquired pneumonia: use of intensive care services and evaluation of American and British Thoracic Society diagnostic criteria. Am. J. Respir. Crit. Care Med. 2002 166 : 717 23.
21. Ewig S, de Roux A, Bauer T, Garcia E, Mensa J et al. Validation of predictive rules and indices of severity for community acquired pneumonia. Thorax 2004 59 : 421 7.
22. Valencia M, Badia JR, Cavalcanti M, Ferrer M, Agusti C et al. Pneumonia severity index class V patients with community-acquired pneumonia: characteristics, outcomes, and value of severity scores. Chest 2007 132 : 515 22.
23. Restrepo MI, Mortensen EM, Velez JA, Frei C, Anzueto A. A comparative study of community-acquired pneumonia patients admitted to the Ward and the Intensive Care Unit. Chest 2008 133 : 610 7.
24. Niederman MS, Mandell LA, Anzueto A, Bass JB, Broughton WA et al. American Thoracic Society. Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am. J. Respir. Crit. Care Med. 2001 163 : 1730 54.
25. Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin. Infect. Dis. 2007 44 (Suppl. 2 S27 S72.
26. Liapikou A, Ferrer M, Polverino E, Balasso V, Esperatti M et al. Severe community-acquired pneumonia: validation of the IDSA/ATS guidelines to predict admission to the ICU. Clin. Infect. Dis. 2009 48 : 377 85.
27. Chalmers JD, Singanayagam A, Hill AT. Predicting the need for mechanical ventilation and/or inotropic support for young adults admitted to the hospital with community-acquired pneumonia. Clin. Infect. Dis. 2008 47 : 1571 4.
28. Labarere J, Stone RA, Obrosky DS, Yealy DM, Meehan TP et al. Factors associated with the hospitalization of low-risk patients with community-acquired pneumonia in a cluster-randomized trial. J. Gen. Intern. Med. 2006 21 : 745 52.
29. Lim WS, Macfarlane JT. Defining prognostic factors in the elderly with community acquired pneumonia: a case controlled study of patients aged ≥ 75 years. Eur. Respir. J. 2001 17 : 200 5.
30. Lim WS, Lewis S, Macfarlane JT. Severity prediction rules in community acquired pneumonia: a validation study. Thorax 2000 55 : 219 23.
31. Naito T, Suda T, Yasuda K, Yamada T, Todate A et al. A validation and potential modification of the pneumonia severity index in elderly patients with community-acquired pneumonia. J. Am. Geriat. Soc. 2006 54 : 1212 9.
32. Chi RC, Jackson LA, Neuzil KM. Characteristics and outcomes of older adults with community-acquired pneumococal bacteremia. J. Am. Geriatr. Soc. 2006 54 : 115 20.
33. Torres OH, Muňoz J, Ruiz D, Ris J, Gich I et al. Outcome predictors of pneumonia in elderly patients: importance of functional assessment. J. Am. Geriatr. Soc. 2004 52 : 1603 9.
34. van der Steen JT, Mehr DR, Kruse RL, Ribbe MW, van der Wal G. Dementia, lower respiratory tract infection, and mortality. J. Am. Med. Dir. Assoc. 2007 8 : 396 403.
35. El-Solh AA, Pineda L, Bouquin P, Mankowski C. Determinants of short and long term functional recovery after hospitalization for community-acquired pneumonia in the elderly: role of inflammatory markers. BMC Geriatr. 2006 6 : 12.
36. Myint PK, Kamath AV, Vowler SL. Severity assessment criteria recommended by the British Thoracic Society (BTS) for community-acquired pneumonia (CAP) and older patients. Should SOAR (systolic blood pressure, oxygenation, age and respiratory rate) criteria be used in older people? A compilation study of two prospective cohorts. Age Ageing 2006 35 : 286 91.
37. Goss CH, Rubenfeld GD, Park DR, Sherbin VL, Goodman MS et al. Cost and incidence of social comorbidities in low-risk community acquired pneumonia patients admitted to a public hospital. Chest 2003 124 : 214 21.
38. Stelianides S, Golmard JL, Carbon C, Bantin B. Influence of socioeconomic status on features and outcome of community-acquired pneumonia. Eur. J. Clin. Microbiol. Infect. Dis. 1999 18 : 704 8.
39. Fine MJ, Hough LJ, Medsger AR, Li YH, Ricci EM et al. The hospital admission decision for patients with community-acquired pneumonia. Results from the pneumonia Patient Outcomes Research Team cohort study. Arch. Intern. Med. 1997 157 : 36 44.
40. Fine MJ, Medsger AR, Stone RA, Marrie TJ, Coley CM et al. The hospital discharge decision for patients with community-acquired pneumonia. Results from the pneumonia patient outcomes research team cohort study. Arch. Intern. Med. 1997 157 : 47 56.
41. Restrepo MI, Mortensen EM, Jacqueline A, Pugh JA, Anzueto A. COPD is associated with increased mortality in patients with community-acquired pneumonia. Eur. Resp. J. 2006 28 : 346 51.
42. Sanders KM, Marras TK, Chan CK. Pneumonia severity index in the immunocompromised. Can. Respir. J. 2006 13 : 89 93.
43. Christensen D, Feldman C, Rossi P, Marrie T, Blasi F et al. HIV infection does not influence clinical outcomes in hospitalized patients with bacterial community-acquired pneumonia: results from the CAPO internantional cohort study. Clin. Infect. Dis. 2005 41 : 554 6.
44. Christ-Crain M, Stolz D, Bingisser R, Muller C, Miedinger D et al. Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. Am. J. Respir. Crit. Care. Med. 2006 174 : 84 93.
45. Masia M, Gutierrez F, Shum C, Padilla S, Navarro JC et al. Usefulness of procalcitonin levels in community-acquired pneumonia according to the patients outcome research team pneumonia severity index. Chest 2005 128 : 2223 9.
46. Boussekey N, Leroy O, Georges H, Devos P, D'Escrivan T et al. Diagnostic and prognostic values of admission procalcitonin levels in community-acquired pneumonia in an intensive care unit. Infection 2005 33 : 257 63.
47. Boussekey N, Leroy O, Alfandari S, Devos P, Georges H et al. Procalcitonin kinetics in the prognosis of severe community-acquired pneumonia. Intensive Care Med. 2006 32 : 469 72.
48. Huang DT, Weissfeld LA, Kellum JA, Yealy DM, Kong L et al. Risk prediction with procalcitonin and clinical rules in community-acquired pneumonia. Ann. Emerg. Med. 2008 52 : 48 58.
49. Kruger S, Ewig S, Marre R, Papassoutiriou J, Richter K et al. Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes. Eur. Resp. J. 2008 31 : 349 55.
50. Christ-Crain M, Stolz D, Jutla S, Couppis O, Müller C et al. Free and total cortisol levels as predictors of severity and outcome in community-acquired pneumonia. Am. J. Resp. Crit. Care Med. 2007 176 : 913 20.
51. Salluh JIF, Bozza FA, Soares M, Verdeal JCR, Casrtro-Faria-Neto HC et al. Adrenal response in severe community-acquried pneumonia: impact on outcomes and disease severity. Chest 2008 134 : 947 54.